Influenza A(H1N1)pdm09 infection and viral load analysis in patients with different clinical presentations rodrigues2020influenza

Study of H1N1pdm09 viral load (VL) in respiratory samples collected 2009-2013 at a tertiary hospital in São Paulo, Brazil. Samples from asymptomatic (AS), symptomatic outpatients (OP) and hospitalised patients (HP) were tested by quantitative one-step real-time RT-PCR targeting the M gene; VL reported as Log10 RNA copies/mL in the paper. A subset of 10 hospitalised patients treated with oseltamivir were followed longitudinally and serial VL measurements (days of treatment) are provided (Fig.2 / CSV).

Analytes

respiratory_influenza_viral_load

Quantitative one-step real-time RT-PCR targeting the influenza M gene. Human RNaseP was used as internal control and Ct values were normalised; viral load expressed as RNA copies per mL (paper reports Log10 RNA copies/mL; CSV measurements are linear copies/mL). Respiratory specimens included nasopharyngeal aspirates (children <2 years) and nasal/oropharyngeal swabs for other patients. Serial measurements in the CSV correspond to days of oseltamivir treatment (Fig.2).

exponential for respiratory_influenza_viral_load

Fitted by censored maximum likelihood. The red line is the median individual; the shaded region is the full range of a simulated cohort drawn from the fitted population, so it shows what simulating from this dataset would produce rather than a confidence interval, with dashed lines at the central 95%. Open triangles are non-detects, drawn at the censoring limit and entering the fit as "below this value" rather than being dropped. See the modelling methods for what these estimates do and do not support.

Biomarker: influenza
Specimen: nasopharyngeal swab and oropharyngeal swab
Units: gc/mL
Gene target: M gene
Participants: 10
Negative samples: 7
Positive samples (not quantifiable): 0
Quantifiable samples: 26
Limit of quantification: unknown
Limit of detection: unknown